• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Convalescent plasma from people vaccinated after COVID-19 infection.新冠病毒感染后接种疫苗者的康复期血浆。
Lancet Microbe. 2021 May;2(5):e171-e172. doi: 10.1016/S2666-5247(21)00060-4. Epub 2021 Mar 23.
2
Convalescent plasma for COVID-19 - encouraging signals of efficacy.用于治疗新冠肺炎的康复期血浆——疗效的鼓舞人心信号。
Br J Haematol. 2021 Feb;192(4):681-682. doi: 10.1111/bjh.17270. Epub 2021 Feb 1.
3
[COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients].[新型冠状病毒肺炎：恢复期血浆疗法仍有应用空间？聚焦免疫功能低下患者]
Rev Med Interne. 2023 Sep;44(9):467-471. doi: 10.1016/j.revmed.2023.08.005. Epub 2023 Sep 7.
4
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
5
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19.免疫抑制患者 COVID-19 的门诊治疗与疫苗加强恢复期血浆治疗。
mBio. 2024 May 8;15(5):e0040024. doi: 10.1128/mbio.00400-24. Epub 2024 Apr 11.
6
[Is convalescent plasma an alternative treatment for Covid-19 patients?].[康复期血浆是新冠病毒肺炎患者的替代治疗方法吗？]
Salud Publica Mex. 2020 Nov-Dec;62(6):870-871. doi: 10.21149/11744.
7
Convalescent plasma for SARS-CoV-2 infection: win or learn.恢复期血浆治疗严重急性呼吸综合征冠状病毒 2 感染：赢或学。
Eur Respir J. 2022 Feb 10;59(2). doi: 10.1183/13993003.02076-2021. Print 2022 Feb.
8
A look-back at convalescent plasma to treat COVID-19.回顾恢复期血浆治疗新冠病毒病
Transfus Apher Sci. 2021 Feb;60(1):103063. doi: 10.1016/j.transci.2021.103063. Epub 2021 Jan 12.
9
Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.用于治疗新冠病毒肺炎的康复期血浆——解读其中的不一致之处
N Engl J Med. 2022 May 5;386(18):1753-1754. doi: 10.1056/NEJMe2204332.
10
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.新冠康复者血浆与严重急性呼吸综合征冠状病毒2病毒变体
Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.

引用本文的文献

1
Modeling the Spread of COVID-19 with the Control of Mixed Vaccine Types during the Pandemic in Thailand.泰国疫情期间混合疫苗类型管控下的新冠病毒传播建模
Trop Med Infect Dis. 2023 Mar 16;8(3):175. doi: 10.3390/tropicalmed8030175.
2
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update.用于COVID-19治疗的康复期血浆（高免疫球蛋白）：最新情况
Process Biochem. 2023 Apr;127:66-81. doi: 10.1016/j.procbio.2023.01.018. Epub 2023 Jan 31.
3
Improved control of SARS-CoV-2 by treatment with a nucleocapsid-specific monoclonal antibody.核衣壳特异性单克隆抗体治疗可改善对 SARS-CoV-2 的控制。
J Clin Invest. 2022 Dec 1;132(23):e162282. doi: 10.1172/JCI162282.
4
Antibody profile in post-vaccinated & SARS-CoV-2 infected individuals.接种疫苗后及 SARS-CoV-2 感染个体的抗体谱。
Indian J Med Res. 2022 May-Jun;155(5&6):538-545. doi: 10.4103/ijmr.ijmr_3330_21.
5
Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2.生产和质量保证人类多克隆抗 SARS-CoV-2 高免免疫球蛋白。
Transfus Med Rev. 2022 Jul;36(3):125-132. doi: 10.1016/j.tmrv.2022.06.001. Epub 2022 Jun 9.
6
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.医护人员中有无既往 COVID-19 史者对 SARS-CoV-2 疫苗接种的 B 和 T 细胞应答。
EBioMedicine. 2021 Aug;70:103539. doi: 10.1016/j.ebiom.2021.103539. Epub 2021 Aug 12.

本文引用的文献

1
Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.在先前感染过 SARS-CoV-2 的医护人员中，单次疫苗接种后的结合抗体和中和抗体滴度。
JAMA. 2021 Apr 13;325(14):1467-1469. doi: 10.1001/jama.2021.3341.
2
Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021.2020 年 12 月至 2021 年 1 月，以色列医护人员的真实世界数据显示，年龄、种族、性别和既往感染状况对接受一剂 BNT162b2 mRNA COVID-19 疫苗后的免疫原性有影响。
Euro Surveill. 2021 Feb;26(6). doi: 10.2807/1560-7917.ES.2021.26.6.2100096.
3
(A Little) Clarity on Convalescent Plasma for Covid-19.关于新冠康复期血浆治疗的一点解读
N Engl J Med. 2021 Feb 18;384(7):666-668. doi: 10.1056/NEJMe2035678. Epub 2021 Jan 13.
4
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.早期高滴度血浆疗法预防老年人重症 COVID-19。
N Engl J Med. 2021 Feb 18;384(7):610-618. doi: 10.1056/NEJMoa2033700. Epub 2021 Jan 6.
5
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.新冠肺炎重症肺炎患者恢复期血浆的随机临床试验。
N Engl J Med. 2021 Feb 18;384(7):619-629. doi: 10.1056/NEJMoa2031304. Epub 2020 Nov 24.
6
Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms.评估三种商业 SARS-CoV-2 血清学检测方法及其在两种检测方法中的性能。
J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.01892-20.
7
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
8
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?采集和评估恢复期血浆用于 COVID-19 治疗：为什么以及如何？
Vox Sang. 2020 Aug;115(6):488-494. doi: 10.1111/vox.12926. Epub 2020 May 3.

Convalescent plasma from people vaccinated after COVID-19 infection.

作者信息

Jabal Kamal Abu, Wiegler Karine Beiruti, Edelstein Michael

机构信息

Ziv Medical Centre, Safed, Israel.

Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.

出版信息

Lancet Microbe. 2021 May;2(5):e171-e172. doi: 10.1016/S2666-5247(21)00060-4. Epub 2021 Mar 23.

DOI:10.1016/S2666-5247(21)00060-4
PMID:33778791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987300/
Abstract
摘要